Research Paper Volume 15, Issue 20 pp 11244—11267
CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model
Figure 5. Prognosis hazard and assessment efficiency of CRCGs-based multi-gene risk-score. (A) Higher CRCGScore predicted worse prognosis in ACC (HR=1.254, P=8.250e-05), KICH (HR=1.117, P=3.780e-05), KIRP (HR=1.172, P=6.730e-07), THCA (HR=1.066, P=4.580e-06), and UVM (HR=1.157, P=1.300e-07). (B) ROC values for survival at 1, 3 and 5 years 0.56, 0.79, and 0.80 in ACC, 0.92, 0.86, and 0.86 in KICH, 0.80, 0.71, and 0.66 in KIRP, 0.81, 0.76, and 0.81 in THCA and 0.94, 0.87, and 0.74 in UVM, respectively.